E. Abdullayev Et Al. , "Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).," Human vaccines & immunotherapeutics , vol.16, no.8, pp.1997-2002, 2020
Abdullayev, E. Et Al. 2020. Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).. Human vaccines & immunotherapeutics , vol.16, no.8 , 1997-2002.
Abdullayev, E., KILIÇ, Ö., BOZAN, G., Kiral, E., Iseri Nepesov, M., & DİNLEYİCİ, E. Ç., (2020). Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).. Human vaccines & immunotherapeutics , vol.16, no.8, 1997-2002.
Abdullayev, Emin Et Al. "Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).," Human vaccines & immunotherapeutics , vol.16, no.8, 1997-2002, 2020
Abdullayev, Emin Et Al. "Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).." Human vaccines & immunotherapeutics , vol.16, no.8, pp.1997-2002, 2020
Abdullayev, E. Et Al. (2020) . "Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).." Human vaccines & immunotherapeutics , vol.16, no.8, pp.1997-2002.
@article{article, author={Emin Abdullayev Et Al. }, title={Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study).}, journal={Human vaccines & immunotherapeutics}, year=2020, pages={1997-2002} }